Thomas James Doyle Kura Oncology, Inc. (KURA) insider trading activity
Thomas James Doyle is SVP, Finance & Accounting of Kura Oncology, Inc.. Currently has a direct ownership of 130,257 shares of KURA, which is worth approximately $1.46 Million. The most recent transaction as insider was on Nov 14, 2025, when has been sold 4,539 shares (Common Stock) at a price of $11.18 per share, resulting in proceeds of $50,746. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
130K
47.7%
3M change
170.84%
12M change
Total Value Held
$1.46 Million
THOMAS JAMES DOYLE Transaction History
TJD
Thomas James Doyle
SVP, Finance & Accounting
San Diego, CA